A Study to Determine the Flow Changes And/or AHI Reduction When Stimulating Two Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea in Adult Subjects
Single Center Proof-of-Concept Study to Determine the Flow Changes And/or AHI Reduction When Stimulating Two Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea in Adult Subjects
1 other identifier
interventional
3
1 country
1
Brief Summary
This Proof-of-Concept study will collect acute and sub-acute flow and/or AHI data following the placement of lead arrays under direct vision. The acute placement and data collection will be collected following the completion of the pre-scheduled neck dissection surgery. The sub-acute data will be collected in a sleep lab during a polysomnography (PSG). Both data collections will be done when stimulating (using an external pulse generator) the hypoglossal nerve or Genioglossus muscle (GG) and a second neural target (Ansa Cervicalis - AC) or the strap muscles (sternohyoid and sternothyroid) with a set of Off-the-Shelf (OTS) electrode arrays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 2, 2024
CompletedFirst Posted
Study publicly available on registry
October 10, 2024
CompletedOctober 10, 2024
October 1, 2024
1.2 years
October 2, 2024
October 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Impacts on acute airway opening
Demonstration of acute airway opening as visually observed under nasoendoscopy when stimulating the HGN or GG and a second target (neural or direct muscle stimulation).
Day 0 to 3
Impacts on airflow during a acute assessment
Acute increase in airflow when stimulating the HGN or GG and a second target (neural or direct muscle stimulation), measured by changes in amplitude (mA) during target stimulation.
Day 0 to 3
Secondary Outcomes (1)
Impacts on airway opening during a sub-acute assessment
Day 0 to 3
Study Arms (1)
Target stimulation
EXPERIMENTALStimulation of a combination of targets: Hypoglossal nerve (HGN) and Ansa Cervicalis (AC), Genioglossus (GG) and AC, HGN and strap muscles, or GG and strap muscles, during an acute and sub-acute phase.
Interventions
Simulation of a combination of: HGN, AC, GG or strap muscles
Eligibility Criteria
You may qualify if:
- Age above 18 years not under guardianship, under curatorship or under judicial protection.
- Body Mass Index (BMI) \< 38 kg/m2.
- Subject must be eligible for neck dissection surgery.
- Written informed consent obtained from the patient prior to performing any study specific procedure.
- Willing and capable to comply with all study requirements, including specific lifestyle considerations, evaluation procedures and questionnaires for the whole duration of the trial.
You may not qualify if:
- Patients meeting any of the following criteria will be excluded from participation in this study:
- Major anatomical or functional abnormalities that would impair the ability of the electrode arrays to be positioned.
- Significant comorbidities that contraindicate surgery or general anesthesia.
- Significant tongue weakness.
- Aerodigestive tract tumor or reconstructive surgery performed at the same time as neck dissection.
- Any other chronic medical illness or condition that contraindicates a surgical procedure or general anesthesia in the judgment of the investigator.
- Prior surgery or treatments that could compromise the placement and effectiveness of the electrode array systems:
- Airway cancer surgery or radiation, or
- Mandible or maxilla surgery in the previous 3 years (not counting dental treatments).
- Other upper airway surgery to remove obstructions related to OSA in the previous 3 months (e.g., uvulopalatopharyngoplasty (UPPP), tonsillectomy, nasal airway surgery).
- Prior hypoglossal nerve stimulation device implantation.
- Currently pregnant or breastfeeding during the study period.
- Concomitant oral or pharyngeal surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Invicta Medical Inc.lead
- Hollywood Private Hospitalcollaborator
Study Sites (1)
Perth Head and Neck Surgery
Perth, Western Australia, 6009, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2024
First Posted
October 10, 2024
Study Start
April 3, 2023
Primary Completion
June 28, 2024
Study Completion
July 1, 2024
Last Updated
October 10, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share